Toshiaki Sakamoto

880 citations

29 papers · 701 indexed · h-index 13

Molecular Biology
Organic Chemistry top 10%
Endocrinology, Diabetes and Metabolism top 5%
Surgery
Oncology

Co-authors: Yuichi Koga Kiichiro Ueta Minoru Tsuda-Tsukimoto Yasuo Yamamoto Sumihiro Nomura Shigeki Sakamaki Eiji Kawanishi Mitsuya Hongu
Topics: Coccidia and coccidiosis research (5 papers)Synthesis and Characterization of Heterocyclic Compounds (4 papers)Synthesis and Reactions of Organic Compounds (4 papers)
Cited by: Endocrinology, Diabetes and Metabolism Organic Chemistry Molecular Biology
Journals: Clinical Cancer Research Biochemical and Biophysical Research Communications Journal of Medicinal Chemistry
Partner nations: Japan United Kingdom United States

In The Last Decade

Toshiaki Sakamoto

28 papers receiving 679 citations

Peers

Countries citing papers authored by Toshiaki Sakamoto

Since Specialization

Citations

This map shows the geographic impact of Toshiaki Sakamoto's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Toshiaki Sakamoto with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Toshiaki Sakamoto more than expected).

Fields of papers citing papers by Toshiaki Sakamoto

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Toshiaki Sakamoto. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Toshiaki Sakamoto. The network helps show where Toshiaki Sakamoto may publish in the future.

Co-authorship network of co-authors of Toshiaki Sakamoto

This figure shows the co-authorship network connecting the top 25 collaborators of Toshiaki Sakamoto. A scholar is included among the top collaborators of Toshiaki Sakamoto based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Toshiaki Sakamoto. Toshiaki Sakamoto is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Differences in the Adverse Event Profiles of Sodium-Glucose Cotransporter 2 Inhibitors used in Patients with Diabetes Mellitus and Heart Failure: An Analysis Using the Japanese Adverse Drug Event Report Database 2024 ·Clinical Drug Investigation ·Toshiaki Sakamoto,Hirotaka Miyamoto,(unknown),(unknown),Tomoaki Akagi,Yukinobu Kodama,Hirofumi Hamano,Yoshito Zamami,Kaname Ohyama	0
2	8-(3-Chloro-4-methoxybenzyl)-8H-pyrido[2,3-d]pyrimidin-7-one derivatives as potent and selective phosphodiesterase 5 inhibitors 2015 ·Bioorganic & Medicinal Chemistry Letters ·Toshiaki Sakamoto,Yuichi Koga,Masataka Hikota,Kenji Matsuki,(unknown),Kohei Kikkawa,Kotomi Fujishige,Jun Kotera,Kenji Omori,Hiroshi Morimoto,Koichiro Yamada	12
3	The discovery of avanafil for the treatment of erectile dysfunction: A novel pyrimidine-5-carboxamide derivative as a potent and highly selective phosphodiesterase 5 inhibitor 2014 ·Bioorganic & Medicinal Chemistry Letters ·Toshiaki Sakamoto,Yuichi Koga,Masataka Hikota,Kenji Matsuki,(unknown),Kohei Kikkawa,Kotomi Fujishige,Jun Kotera,Kenji Omori,Hiroshi Morimoto,Koichiro Yamada	25
4	Design and synthesis of novel 5-(3,4,5-trimethoxybenzoyl)-4-aminopyrimidine derivatives as potent and selective phosphodiesterase 5 inhibitors: Scaffold hopping using a pseudo-ring by intramolecular hydrogen bond formation 2014 ·Bioorganic & Medicinal Chemistry Letters ·Toshiaki Sakamoto,Yuichi Koga,Masataka Hikota,Kenji Matsuki,(unknown),Kohei Kikkawa,Kotomi Fujishige,Jun Kotera,Kenji Omori,Hiroshi Morimoto,Koichiro Yamada	21
5	C-Glucosides with heteroaryl thiophene as novel sodium-dependent glucose cotransporter 2 inhibitors 2013 ·Bioorganic & Medicinal Chemistry ·Yuichi Koga,Shigeki Sakamaki,Mitsuya Hongu,Eiji Kawanishi,Toshiaki Sakamoto,Yasuo Yamamoto,Hirotaka Kimata,Keiko Nakayama,Chiaki Kuriyama,Yasuaki Matsushita,Kiichiro Ueta,Minoru Tsuda-Tsukimoto,Sumihiro Nomura	26
6	Blockade of the ERK pathway enhances the therapeutic efficacy of the histone deacetylase inhibitor MS-275 in human tumor xenograft models 2013 ·Biochemical and Biophysical Research Communications ·Toshiaki Sakamoto,Kei‐ichi Ozaki,(unknown),(unknown),Shinichi Uesato,Kazushi Watanabe,Susumu Tanimura,Takehiko Koji,Michiaki Kohno	16
7	N-glucosides as human sodium-dependent glucose cotransporter 2 (hSGLT2) inhibitors 2013 ·Bioorganic & Medicinal Chemistry Letters ·Yasuo Yamamoto,Eiji Kawanishi,Yuichi Koga,Shigeki Sakamaki,Toshiaki Sakamoto,Kiichiro Ueta,Yasuaki Matsushita,Chiaki Kuriyama,Minoru Tsuda-Tsukimoto,Sumihiro Nomura	21
8	Discovery of Canagliflozin, a Novel C-Glucoside with Thiophene Ring, as Sodium-Dependent Glucose Cotransporter 2 Inhibitor for the Treatment of Type 2 Diabetes Mellitus 2010 ·Journal of Medicinal Chemistry ·Sumihiro Nomura,Shigeki Sakamaki,Mitsuya Hongu,Eiji Kawanishi,Yuichi Koga,Toshiaki Sakamoto,Yasuo Yamamoto,Kiichiro Ueta,Hirotaka Kimata,Keiko Nakayama,Minoru Tsuda-Tsukimoto	307
9	Blockade of the Extracellular Signal-Regulated Kinase Pathway Enhances the Therapeutic Efficacy of Microtubule-Destabilizing Agents in Human Tumor Xenograft Models 2010 ·Clinical Cancer Research ·Kazushi Watanabe,Susumu Tanimura,Aya Uchiyama,Toshiaki Sakamoto,(unknown),Kei‐ichi Ozaki,Michiaki Kohno	13
10	Blockade of the ERK or PI3K–Akt signaling pathway enhances the cytotoxicity of histone deacetylase inhibitors in tumor cells resistant to gefitinib or imatinib 2009 ·Biochemical and Biophysical Research Communications ·Kei‐ichi Ozaki,(unknown),Nobuyuki Baba,(unknown),Toshiaki Sakamoto,Shinya Kimura,Susumu Tanimura,Michiaki Kohno	41
11	Histone deacetylase inhibitors enhance the chemosensitivity of tumor cells with cross‐resistance to a wide range of DNA‐damaging drugs 2008 ·Cancer Science ·Kei‐ichi Ozaki,(unknown),Masashi Tanaka,Toshiaki Sakamoto,Susumu Tanimura,Michiaki Kohno	76
12	Ruthenium-catalysed reductive cleavage of allylic esters with formic acid and triethylamine. Application to short-step synthesis of α-hydroxy acids 1994 ·Journal of Organometallic Chemistry ·Yooichiroh Maruyama,(unknown),(unknown),Toshiaki Sakamoto,Isao Shimizu,Akio Yamamoto	11
13	5,10,15,20-Tetrakis(2-amino-6-methoxycarbonylphenyl)porphyrin. Synthesis and Separation of Atropisomers Useful for Porphyrin Architecture 1993 ·Chemistry Letters ·Norikazu Nishino,Toshiaki Sakamoto,Hiroshi Kiyota,Hisakazu Mihara,(unknown),Tsutomu Fujimoto	3
14	A novel heterocyclic compound. Synthesis and reactivities of an oxazolo(3,2-a)thieno(3,2-d)-pyrimidine derivative. 1989 ·Chemical and Pharmaceutical Bulletin ·Hiroshi Fukumi,(unknown),Toshiaki Sakamoto	7
15	Condensed Thienopyrimidines 5. Studies on the Thermal Cyclization of Various ortho-Formylthiophenecarbamates with Ethanolamine 1989 ·Heterocycles ·Hiroshi Fukumi,(unknown),Toshiaki Sakamoto	1
16	Condensed thienopyrimidines. I. Synthesis and gastric antisecretory activity of 2,3-dihydro-5H-oxazolothienopyrimidin-5-one derivatives. 1989 ·Chemical and Pharmaceutical Bulletin ·(unknown),Toshiaki Sakamoto,Keiichi Tabata,Kazuo Endo,Keiichi Ito,(unknown),Hiroshi Fukumi	8
17	Synthesis and Antifungal Activity of Trihaloallyl and Trihaloacryl Derivatives 1984 ·Holzforschung ·(unknown),(unknown),(unknown),Toshiaki Sakamoto,(unknown),Kiyoshi Konishi,(unknown),(unknown),Shigeki Ono,(unknown)	3
18	Studies on anticoccidial agents. 13. Synthesis and anticoccidial activity of nitropyridine-2- and -3-sulfonamides and derivatives 1980 ·Journal of Medicinal Chemistry ·(unknown),(unknown),(unknown),Toshiaki Sakamoto,(unknown),(unknown),(unknown)	15
19	Studies on anticoccidial agents. IX. The preparation of some .ALPHA.4-norpyridoxol analogs. 1976 ·Agricultural and Biological Chemistry ·(unknown),(unknown),Toshiaki Sakamoto	1
20	Studies on anticoccidial agents. VI. Modification at the 2-position of 4-deoxypyridoxol and .ALPHA.-norpyridoxol. 1976 ·Agricultural and Biological Chemistry ·(unknown),(unknown),Toshiaki Sakamoto,Fumiko Saito	1

About Toshiaki Sakamoto

Toshiaki Sakamoto is a scholar working on Organic Chemistry, Animal Science and Zoology and Small Animals, having authored 29 papers that have together received 701 indexed citations. Recurring topics across this work include Coccidia and coccidiosis research (5 papers), Synthesis and Characterization of Heterocyclic Compounds (4 papers) and Synthesis and Reactions of Organic Compounds (4 papers). The work is most often cited by research in Endocrinology, Diabetes and Metabolism (215 citations), Organic Chemistry (306 citations) and Molecular Biology (331 citations). Toshiaki Sakamoto has collaborated with scholars based in Japan, United Kingdom and United States. Frequent co-authors include Yuichi Koga, Kiichiro Ueta, Minoru Tsuda-Tsukimoto, Yasuo Yamamoto, Sumihiro Nomura, Shigeki Sakamaki, Eiji Kawanishi, Mitsuya Hongu, Keiko Nakayama and Hirotaka Kimata. Their work appears in journals such as Clinical Cancer Research, Biochemical and Biophysical Research Communications and Journal of Medicinal Chemistry.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact